Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$3.4B
Avg Funding
$229.0M
Global Reach
4
countries

Top Cities for Biopharma

San Francisco
Arlington
Los Angeles
Hanover
Tokyo
Little Rock

Recently Funded Companies

Export
San Francisco, United States

Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.

$3.0B raised
Sep 2021

Founder Contacts

41,000+ verified contacts

Arlington, United States

Revere Pharmaceuticals develops a drug discovery and development platform targeting Rac1 and its genomic variants.

$1.1M raised
Sep 2021

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

Pythia Labs is an LA-based start-up that crafts computational solutions to facilitate the discovery and design of biomolecular therapeutics.

$10.0M raised
Sep 2021

Founder Contacts

41,000+ verified contacts

Hanover, Germany

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

$75.3M raised
Aug 2021

Founder Contacts

41,000+ verified contacts

Tokyo, Japan

Molcure is a high-speed, high-quality, high-variation antibody screening & design system combining biology, automation and bioinformatics

$7.3M raised
Aug 2021

Founder Contacts

41,000+ verified contacts

Little Rock, United States

Captura Biopharma is an emerging biotechnology company engaged in the development and commercialization of heavy metal chelators.

$50.0M raised
Aug 2021

Founder Contacts

41,000+ verified contacts

Baltimore, United States

Cerecor discovers, develops and commercializes neuroscience drugs.

$10.0M raised
Aug 2021

Founder Contacts

41,000+ verified contacts

Richmond, United States

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND, to commercial stage.

$150.0M raised
Aug 2021

Founder Contacts

41,000+ verified contacts

Fort Collins, United States

Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.

$75.0M raised
Jul 2021

Founder Contacts

41,000+ verified contacts

Indianapolis, United States

Formulary Insights help biopharmaceutical investors, marketers, and leaders understand and anticipate payer perceptions of their product.

$1.7M raised
Jul 2021

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

$50.0M raised
Jul 2021

Founder Contacts

41,000+ verified contacts

Concord, United States

Kantum Pharma is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI.

$3.5M raised
Jul 2021

Founder Contacts

41,000+ verified contacts

San Diego, United States

EHP is a biotech company developing biotechnology and cannabinoids science and technology to treat incurable diseases.

$300K raised
Jul 2021

Founder Contacts

41,000+ verified contacts

Tokyo, Japan

RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.

Jul 2021

Founder Contacts

41,000+ verified contacts

Gisborne, New Zealand

Rua Bioscience develops medicinal cannabis products.

$262K raised
Jul 2021

Founder Contacts

41,000+ verified contacts

Showing 901 to 915 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$229.0M
Total Funding Tracked
$3.4B
Countries Represented
4

Distribution by Funding Stage

Other15 companies

Top Cities for Biopharma

1.Tokyo
2 companies$7.3M
2.San Francisco
1 companies$3.0B
3.Arlington
1 companies$1.1M
4.Los Angeles
1 companies$10.0M
5.Hanover
1 companies$75.3M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked